Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/299
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLakhani, Urvashi-
dc.date.accessioned2024-03-03T06:44:57Z-
dc.date.available2024-03-03T06:44:57Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/299-
dc.language.isoen_USen_US
dc.publisherIIHMR Universityen_US
dc.subjectPharmaceuticalen_US
dc.subjectMarket Assessmenten_US
dc.subjectImmunotherapyen_US
dc.subjectNSCLCen_US
dc.subjectChinaen_US
dc.titleMarket Assessment of Immunotherapy For Treatment of NSCLC in China: Present and Outlooken_US
dc.typeDissertationen_US
dc.guideChowhan, Sudhinder Singhen_US
dc.organizationnamePharmaACE Analytics Pvt. Ltden_US
Appears in Collections:2022

Files in This Item:
File Description SizeFormat 
Urvashi-dis.pdfDissertation Report471.9 kBAdobe PDF Preview PDFDownload
Urvashi-ppt.pdfPresentation479.45 kBAdobe PDF Preview PDFDownload
Urvashi-int.pdfInternship156.55 kBAdobe PDF Preview PDFDownload


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.